Cellectis BioResearch Acquires Assets from Cyto Pulse Sciences, Inc.
9/9/2010 2:31:23 PM
More...
|
Cyto Pulse Sciences, Inc., the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers
2/22/2010 11:01:57 AM
More...
|
Cyto Pulse Sciences, Inc., the Karolinska Hospital/Institutet and SMI Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Evaluating a CEA-based Vaccine in Patients with Colorectal Cancer.
11/4/2009 11:04:53 AM
More...
|
Cyto Pulse Sciences, Inc. And The Center For Vaccine Development Received IRB Approval For A Phase I Tolerability Study Of Easy Vax
2/11/2009 9:42:57 AM
More...
|
Cyto Pulse Sciences, Inc., The Karolinska Institute And Uppsala University Hospital Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Using a Xenogenic PSA DNA Vaccine
10/13/2008 10:08:34 AM
More...
|
Cyto Pulse Sciences, Inc., University Hospital Uppsala, and Cancer Center Karolinska Sign Agreement for Clinical Evaluation of Prostate Cancer DNA Vaccine
5/15/2007 1:40:10 PM
More...
|
Cyto Pulse Sciences, Inc. Awarded $2 Million By National Institutes of Health (NIH) For DNA Vaccine Delivery System Commercialization
8/17/2006 9:55:41 AM
More...
|
Cyto Pulse Sciences, Inc. Awarded Grant By Maryland Technology Development Corporation For A Smallpox DNA Vaccine Delivery Project
2/3/2006 11:02:20 AM
More...
|
Medarex, Inc. (MEDX) And Cyto Pulse Sciences, Inc. Announce Research And License Agreement
10/19/2005 5:09:33 PM
More...
|
Cyto Pulse Sciences, Inc. Working With Walter Reed Army Institute of Research For Dengue Fever Vaccine Delivery Development
10/19/2005 5:09:16 PM
More...
|